Literature DB >> 27246794

Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.

Takayuki Shimizu1, Ken-Ichi Inoue2, Hiroyuki Hachiya1, Norisuke Shibuya1, Taku Aoki1, Keiichi Kubota1.   

Abstract

BACKGROUND: Frequent alterations are observed in glucose metabolism in hepatocellular carcinoma (HCC). Activation of various enzymes, including ones involved in the pentose phosphate pathway, by NF-E2-related factor 2 (NRF2), controls redox homeostasis in HCC. However, the mechanisms mediating NRF2 activation remain unclear. Here, we aimed to investigate the correlation between NRF2, Kelch-like ECH-associated protein 1 (KEAP1) syntheses and p62 phosphorylation in HCC.
METHODS: Biospecimens were collected from 30 patients with HCC. Protein samples were prepared through subcellular localization. Protein synthesis and phosphorylation were measured by sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblotting. Statistical correlations among immunoblotting data and clinical features were analyzed using SPSS.
RESULTS: Compared to non-tumor counterpart, phosphorylated p62 was accumulated in HCC (12/30; 40% of patients). Nuclear localization of NRF2 was frequently augmented in HCC (19/30; 63.3%). Statistically, p62 phosphorylation was associated with augmented activation of NRF2 (P = 0.001). Accumulation of p62 per se was moderately associated with NRF2 activation (P = 0.132). Loss of KEAP1 protein, on the other hand, poorly correlated with NRF2 activation (P = 1.000).
CONCLUSION: In Japanese HCC, NRF2 activation is associated with phosphorylation of p62, but not with KEAP1 status.
© 2016 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Hepatocellular carcinoma; NF-E2-related factor 2; Pentose phosphate pathway; Selective autophagy; p62

Mesh:

Substances:

Year:  2016        PMID: 27246794     DOI: 10.1002/jhbp.364

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  9 in total

Review 1.  p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.

Authors:  Koji Taniguchi; Shinichiro Yamachika; Feng He; Michael Karin
Journal:  FEBS Lett       Date:  2016-08-06       Impact factor: 4.124

2.  Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells.

Authors:  Genki Tanaka; Ken-Ichi Inoue; Takayuki Shimizu; Kazumi Akimoto; Keiichi Kubota
Journal:  Cancer Med       Date:  2016-08-03       Impact factor: 4.452

Review 3.  Genetic alterations in hepatocellular carcinoma: An update.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

Review 4.  Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.

Authors:  Germana Castelli; Elvira Pelosi; Ugo Testa
Journal:  Cancers (Basel)       Date:  2017-09-20       Impact factor: 6.639

Review 5.  p62/SQSTM1: 'Jack of all trades' in health and cancer.

Authors:  Pablo Sánchez-Martín; Tetsuya Saito; Masaaki Komatsu
Journal:  FEBS J       Date:  2018-12-18       Impact factor: 5.542

Review 6.  Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance.

Authors:  Azhwar Raghunath; Kiruthika Sundarraj; Frank Arfuso; Gautam Sethi; Ekambaram Perumal
Journal:  Cancers (Basel)       Date:  2018-12-03       Impact factor: 6.639

7.  Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.

Authors:  Katarína Smolková; Edit Mikó; Tünde Kovács; Alberto Leguina-Ruzzi; Adrienn Sipos; Péter Bai
Journal:  Antioxid Redox Signal       Date:  2020-03-18       Impact factor: 8.401

Review 8.  Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review).

Authors:  Jinlong Tang; Yuan Li; Shuli Xia; Jinfan Li; Qi Yang; Kefeng Ding; Honghe Zhang
Journal:  Int J Oncol       Date:  2021-08-20       Impact factor: 5.650

Review 9.  Chemopreventive activity of sulforaphane.

Authors:  Xin Jiang; Ye Liu; Lixin Ma; Rui Ji; Yaqin Qu; Ying Xin; Guoyue Lv
Journal:  Drug Des Devel Ther       Date:  2018-09-11       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.